Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (2) | Back to Search
Improving care in high-risk post-myocardial infarction patients: from pilot to national roll-out
- At: Glasgow (Scotland) (2018)
- Type: Poster
- Poster code: POS-HPS-056
- By: FORSYTH, Paul (NHS Greater Glasgow & Clyde, Pharmacy & Prescribing Support Unit (PPSU))
- Co-author(s): Paul Forsyth
Lynsey Moir: Pharmacy & Prescribing Support Unit (PPSU), NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
Iain Speirits: Pharmacy & Prescribing Support Unit (PPSU), NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
Fiona Reid: Pharmacy, NHS Education for Scotland, Glasgow, United Kingdom
Anne Watson: Pharmacy, NHS Education for Scotland, Glasgow, United Kingdom
Steve McGlynn: Pharmacy & Prescribing Support Unit (PPSU), NHS Greater Glasgow & Clyde, Glasgow, United Kingdom
Clare Murphy: Cardiology Department, Royal Alexandra Hospital, NHS Greater Glasgow & Clyde, Paisley, United Kingdom - Abstract:
Background
Left ventricular systolic dysfunction (LVSD) is one of the strongest predictors of outcomes Post-Myocardial Infarction (Post-MI).1 The optimisation of angiotensin converting enzyme inhibitors (ACEIs) and beta-blockers (βBs) is crucial in improving outcomes.2Methods
Quality improvement project in patients with incident MI and echo.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023